4502.T

Takeda Pharmaceutical Company Limited JPX · 4502.T

$5,552.00 -3.00 (-0.05%)

Blow-off · +2.02σ Hot zone Grade C

+ Compare Open in Sniper

Valuation

Market cap $8,865.2B

P/E (ttm) —

Forward P/E 39.5

Beta (5y) 0.09

Shares out 1,596.8M

Div yield 3.67%

Profitability & returns

ROE -2.1%

Net margin -3.4%

FCF margin 14.9%

Debt / equity 0.74

Trading information

Last price $5552.00

Day range $5471.00 – $5589.00

52-wk range $4710.00 – $6033.00

Avg volume 4.2M

RSI (2) 92.2

Trend zone Blow-off

52-week range · today's price

$4710.00$6033.00

Company

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Exchange JPX

Next earnings 2026-07-30

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Re…